Orbifloxacin Oral Suspension
630 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
630
Total Reports
69
Deaths Reported
1100.0%
Death Rate
Active Ingredients
Orbifloxacin Oral Suspension
Administration Routes
UnknownOralOphthalmicTopicalSubcutaneous
Species Affected
Unknown 336
Cat 232
Dog 52
Human 5
Rabbit 2
Parrot 1
Guinea Pig 1
Hedgehog 1
Most Affected Breeds
Unknown 342
Domestic Shorthair 150
Domestic Longhair 19
Cat (unknown) 16
Crossbred Canine/dog 12
Domestic Mediumhair 12
Siamese 10
Chihuahua 7
Persian 5
Maltese 4
Most Reported Reactions
Containers, Damaged 103
Containers, Leaking 97
Blindness 47
Death by euthanasia 40
Appearance, Abnormal 36
Bottles, Damaged 34
Lethargy (see also Central nervous system depression in 'Neurological') 33
Underfilling, Container 32
Defect Unknown/Not Specified 31
Dilated pupils 30
Emesis (multiple) 29
Death 27
Outcome Breakdown
Ongoing
84 (28.6%)
Recovered/Normal
73 (24.8%)
Euthanized
40 (13.6%)
Outcome Unknown
38 (12.9%)
Recovered with Sequela
30 (10.2%)
Died
29 (9.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.